p-Coumaric acid protects against D-galactose induced neurotoxicity by attenuating neuroinflammation and apoptosis in mice brain
- PMID: 35913570
- DOI: 10.1007/s11011-022-01007-3
p-Coumaric acid protects against D-galactose induced neurotoxicity by attenuating neuroinflammation and apoptosis in mice brain
Abstract
D-galactose (D-gal) induced senescence in rodents is a widely used model for assessment of molecules affecting brain ageing. Chronic administration of D-gal causes neuroinflammation leading to cognitive deficit and memory impairment which represent Alzheimer's dementia. In present study, we investigated the neuroprotective effects of the natural phenol, p-Coumaric acid (PCA) and its underlying mechanism in the chronic D-gal treated mice. Subcutaneous administration of D-gal (150 mg/kg) to Swiss albino mice for 42 consecutive days resulted in cognitive impairment as observed in Morris water maize (MWM) and Y maze test, which was ameliorated by concurrent treatment with PCA (80 mg/kg, and 100 mg/kg, p.o.). Importantly, PCA treatment attenuated the D-gal induced oxidative stress and significantly inhibited acetylcholinesterase (AChE) activity in mice brain. Furthermore, PCA treatment significantly lowered levels of inflammatory marker nuclear factor kappa B (NFκB) and reduced levels of proapoptotic enzyme caspase3. We also observed that PCA treatment exhibited β-secretase enzyme (BACE1) inhibitory effect. However, our results revealed that PCA treatment failed to decrease the level of advanced glycation end products both in vitro and in vivo. Taken together, current study demonstrated the significant neuroprotective effect of PCA against D-gal induced oxidative stress, neuroinflammation, cognitive impairment and apoptosis.
Keywords: Apoptosis; BACE1; D-galactose; NFκB; Neuroinflammation; p-Coumaric acid.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
In vitro antiglycating effect and in vivo neuroprotective activity of Trigonelline in d-galactose induced cognitive impairment.Pharmacol Rep. 2018 Apr;70(2):372-377. doi: 10.1016/j.pharep.2017.09.006. Epub 2017 Sep 28. Pharmacol Rep. 2018. PMID: 29477946
-
Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse.Brain Res Bull. 2017 Sep;134:262-272. doi: 10.1016/j.brainresbull.2017.08.014. Epub 2017 Sep 1. Brain Res Bull. 2017. PMID: 28867383
-
Ferulic acid ameliorates memory impairment in d-galactose-induced aging mouse model.Int J Food Sci Nutr. 2016 Nov;67(7):806-17. doi: 10.1080/09637486.2016.1198890. Epub 2016 Jun 26. Int J Food Sci Nutr. 2016. PMID: 27345860
-
Protective effect of tetrahydropalmatine against d-galactose induced memory impairment in rat.Physiol Behav. 2016 Feb 1;154:114-25. doi: 10.1016/j.physbeh.2015.11.016. Epub 2015 Nov 22. Physiol Behav. 2016. PMID: 26592138
-
p-Coumaric acid mitigates lipopolysaccharide induced brain damage via alleviating oxidative stress, inflammation and apoptosis.J Pharm Pharmacol. 2022 Apr 20;74(4):556-564. doi: 10.1093/jpp/rgab077. J Pharm Pharmacol. 2022. PMID: 34190326
Cited by
-
The efficacy and mechanism of berberine in improving aging-related cognitive dysfunction: A study based on network pharmacology.Front Neurosci. 2023 Jan 20;17:1093180. doi: 10.3389/fnins.2023.1093180. eCollection 2023. Front Neurosci. 2023. PMID: 36743801 Free PMC article.
-
Non-Enzymatic Antioxidants against Alzheimer's Disease: Prevention, Diagnosis and Therapy.Antioxidants (Basel). 2023 Jan 12;12(1):180. doi: 10.3390/antiox12010180. Antioxidants (Basel). 2023. PMID: 36671042 Free PMC article. Review.
-
Non-transgenic rodent models of Alzheimer's disease for preclinical research: a review.Mol Biol Rep. 2025 May 14;52(1):456. doi: 10.1007/s11033-025-10549-5. Mol Biol Rep. 2025. PMID: 40366433 Review.
-
Chelidonic acid abrogates oxidative stress and memory dysfunction in experimental aging rats.Turk J Biol. 2024 Oct 30;48(6):432-441. doi: 10.55730/1300-0152.2717. eCollection 2024. Turk J Biol. 2024. PMID: 39758839 Free PMC article.
References
-
- Abdel-Moneim A, Yousef AI, Abd El-Twab SM, Abdel Reheim ES, Ashour MB (2017) Gallic acid and p-coumaric acid attenuate type 2 diabetes-induced neurodegeneration in rats. Metab Brain Dis 32(4):1279–1286. https://doi.org/10.1007/s11011-017-0039-8 - DOI - PubMed
-
- Abdel-Wahab M (2003) Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rat’s heart. Pharmacol Res 48(5):461–465. https://doi.org/10.1016/S1043-6618(03)00214-7 - DOI - PubMed
-
- Chen H, Virk MS, Chen F (2016) Phenolic acids inhibit the formation of advanced glycation end products in food simulation systems depending on their reducing powers and structures. Int J Food Sci Nutr 67(4):400–411. https://doi.org/10.3109/09637486.2016.1166187 - DOI - PubMed
-
- Cosma G, Gardner H, Shi X, Castranova V, Vallyathan V (2000) Effect of antioxidant protection by p-coumaric acid on low-density lipoprotein cholesterol oxidation. Am J Physiol Cell Physiol 279(4 48-4):954–960. https://doi.org/10.1152/ajpcell.2000.279.4.c954 - DOI
-
- Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M (1993) A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radical Biol Med 15(4):353–363. https://doi.org/10.1016/0891-5849(93)90035-S - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources